Browsing Tag
Lupin
81 posts
Glenmark Pharmaceuticals (NSE: GLENMARK) launches GLIPIQ semaglutide in India at Rs 325 a week as generic GLP-1 era starts
Glenmark Pharmaceuticals launches GLIPIQ semaglutide in India from Rs 325 a week. Analysis of pricing, competition, and what it means for GLP-1 access. Read more.
LupinLife launches Ayurvedic liquid laxative Softovac Liquifibre
LupinLife, the consumer healthcare division of global pharmaceutical giant Lupin Limited, announced a significant entry into the Indian…
Lupin Diagnostics opens advanced regional reference laboratory in Chennai
Global pharmaceutical giant, Lupin Limited, has made a significant stride in healthcare innovation with the launch of its…
Lupin gets FDA nod for Allopurinol Tablets, eyeing share in $88m market
Global pharmaceutical company Lupin Limited has announced its receipt of approval from the United States Food and Drug…
Lupin Limited launches Turqoz Tablets in US, aims to expand contraceptive market
Global pharmaceutical giant Lupin Limited has made a significant entry into the U.S. contraceptive market with the launch…
Lupin obtains tentative FDA approval for generic Canagliflozin Tablets
Global pharmaceutical leader, Lupin Limited, announced its significant achievement of receiving tentative approval from the United States Food…
Lupin gains FDA approval for generic Pitavastatin Tablets, targeting $298m market
Global pharmaceutical giant Lupin Limited announced its receipt of approval from the United States Food and Drug Administration…
Lupin Limited bags FDA approval for Generic Ganirelix Acetate Injection
Lupin Limited, a global pharma major, has announced its receipt of approval from the United States Food and…
Zydus and Lupin forge alliance for NAFLD and NASH treatment in India
In a significant move within the pharmaceutical industry, Zydus Lifesciences Limited, renowned for its global lifesciences innovations, and…
Lupin gains FDA nod for generic Diflucan Tablets production
Lupin Limited, a recognized global pharmaceutical powerhouse, proudly announced its receipt of the much-anticipated approval from the US…